Answers are grounded in this paper and cite their sources.
More and more proteins including biopharmaceuticals and enzymes have attracted growing interest in industrial and scientific applications due to their high specificity, efficiency, and environmental compatibility. However, their practical application is often limited by their sensitivity to environment conditions. High or low pH, organic solvents, and high temperature can all promote protein unfolding, aggregation, and loss of function, often requiring costly cold-chain storage and transport, limiting the bioavailabilities and applications. This study is the first to systematically investigate the stability and bioactivity of the protein crystallization product in both the solid state and dissolved in the solution state. The liquid and solid samples of lysozyme, as a model protein, were exposed to 10 to nearly 100% ethanol, and the bioactivity was determined using Micrococcus lysodeikticus cells. Lysozyme crystals retained a substantially higher activity than dissolved lysozyme in the solution after ethanol exposure. The lysozyme crystals remained clearly visible after 120 min exposure to 90% and nearly 100% ethanol. Under most conditions tested with 10, 50, and 90% ethanol, the crystalline-phase protein provided over 2 times to over 20 times greater protection effect on bioactivity than the liquid-phase protein, depending on the exposure conditions and protective performance evaluated. These findings proved that crystallization can provide a simple physical strategy for enhancing protein resistance to denaturation, a reliable route to improve protein storage, formulation, and use in challenging environments.
No takes yet. Share an insight, caveat, or question.
Owen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: